SkinMedica’s newer HA5: hydration claims and younger-looking skin

The US record calls the product HA5 Hydra Collagen Hydrator with Vegan Collagen and contrasts it with legacy HA5 Rejuvenating Hydrator. The reviewed net-volume field is blank, so this review does not borrow a container quantity from an older listing. A familiar family name is not enough to establish the exact preparation being considered. Current HA5 identity

The listed offer showed $192 for a one-time purchase and $153.60 under a limited subscription discount. These are published commercial details, not a tested order or stock guarantee. Our OneSkin review offers another appearance-care discussion, with its own product identity and study questions rather than an assumed comparison between technologies. HA5 offer and legacy distinction

SkinMedica says the newer formula has twice the hyaluronic acid of the previous formulation and compares 48-hour hydration with the legacy product’s 24-hour claim. This identifies a company-reported change. It does not provide an absolute HA concentration, a complete current ingredient list or the full comparative study needed to examine the claimed difference. New-versus-legacy explanation

That limit is useful when a discussion begins with “more” or “longer.” Both words need a reference, and neither by itself establishes an individual benefit. The product record supplies the manufacturer’s stated reference to legacy HA5, but this review does not import older formula details or treat the relative comparison as an independent measurement. HA5 formulation comparison

The headline about looking roughly three years younger is attributed to patients at week twelve, with data on file at SkinMedica. It is not presented as a biological-age assay. Preserving the words “reported” and “looked” prevents a subjective appearance judgment from becoming a claim that the product changed someone’s age or treated a systemic condition. Patient-reported age appearance

FTC guidance asks whether the outcome studied matches the advertised benefit. Here, the relevant question is how patients made that judgment and what study conditions supported it. The guidance does not independently verify SkinMedica’s data. Without the complete account, the appearance description can be reported accurately without promising the same judgment for another reader. FTC outcome relevance

At twelve weeks, the company reports that 90% said skin looked dewy and healthy, 83% said it looked plumper, 97% agreed skin quality improved and 93% said they felt more confident. Each is labeled with 29 patients. These are different questionnaire responses, not four laboratory measurements or proof that every respondent experienced the same change. HA5 patient responses

The reviewed description does not provide a comparison group or the full data-on-file report. That leaves specific questions about the questionnaires and study design, rather than grounds to calculate a personal success rate. Our Paula’s Choice Booster review is another product-evidence discussion to read without treating its study as a direct HA5 comparison. SkinMedica study wording

The page presents four individual examples, with ages, skin-type descriptions and immediate or twelve-week timepoints. It says the photographs are unretouched and taken in parallel-polarized lighting, and notes that individual results may vary. Those qualifications describe the manufacturer’s presentation; this review did not independently authenticate the images or establish that they represent the whole study group. HA5 photo descriptions

FTC guidance explains that testimonials and endorsements still need evidence for the results they imply. Applied to this record, an individual example should remain distinct from a typical outcome or questionnaire percentage. A favorable image cannot supply the missing complete formula or explain every part of the clinical account on its own. FTC testimonial context

SkinMedica distinguishes a moisturizer, described as a cream or lotion that prevents dryness, from a hydrator, described as supporting water-related molecules in skin. This is its explanation of the product’s role. The terminology does not itself establish a hormone-treatment category or a measured advantage over every product called a moisturizer. Manufacturer hydrator explanation

AAD explains that retaining moisture can improve the appearance of some fine lines. That general context is useful beside a hydration-focused product, but it does not verify HA5’s newer-formula or questionnaire claims. Our facial versus menopause treatment guide similarly keeps a skin-appearance discussion distinct from another medical treatment’s purpose. AAD moisture context

The newer title, relative HA statement and patient-reported results make this a specific product discussion rather than a review of all HA5 preparations. The practical questions are the current complete declaration, container quantity and full study explanation. Those missing details should not be filled with an older bottle’s information simply because the family name is familiar. Current HA5 description

The prescription questions guide and medication-list guide address different care records. FDA’s intended-use framework helps distinguish appearance care from medical treatment without validating this product. HA5 is most useful to discuss when its exact version and reported outcomes stay together, leaving personal suitability and treatment decisions outside the review. FDA intended-use explanation